Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Procopio

Showing results (71-80 of 289) with videos related to

Pageof 29
Sort By:
Clinical Genitourinary Cancer|February 27, 2018
Exposure to Multiple Lines of Treatment and Survival of Patients With Metastatic Renal Cell Carcinoma: A Real-world AnalysisRaffaele Ratta, Elena Verzoni, Massimo Di Maio, et al.
Tumori|January 31, 2007
Kit protein (CD117) and proliferation index (Ki-67) evaluation in well and poorly differentiated neuroendocrine tumorsLeonardo Ferrari, Silvia Della Torre, Paola Collini, et al.
Expert Review of Anticancer Therapy|June 10, 2026
Local treatment of the primary tumour in mHSPC in the ARPI era: incremental value or overtreatment?Simone Rota, Melanie Claps, Eleonora Gusmaroli, et al.
Tumori|July 5, 2003
Current treatments of neuroendocrine tumors role of biotherapy and chemotherapySilvia Della Torre, Giuseppe Procopio, Alberto Fusi, et al.
Tumori|February 12, 2004
Renal cancer treatment: a review of the literatureLuca Gattinoni, Massimiliano Alù, Leonardo Ferrari, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 29, 2014
Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinibRoberto Iacovelli, Giacomo Cartenì, Michele Milella, et al.
Pragmatic and Observational Research|November 17, 2025
Real-World Treatment Patterns and Overall Survival (OS) of Patients with Metastatic Castration-Resistant Prostate Cancer in ItalyMelania Dovizio, Daniela Castelletti, Paolo Luraghi, et al.
BJU International|November 17, 2010
Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castrationGiuseppe Procopio, Valentina Guadalupi, Maria Olga Giganti, et al.
Drugs in R&D|August 13, 2017
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?Paolo Grassi, Elena Verzoni, Raffaele Ratta, et al.
Oncology|November 8, 2014
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies: overall results from a large cohort of patientsGiuseppe Procopio, Isabella Testa, Elena Verzoni, et al.
Pageof 29

Showing results (71-80 of 289) with videos related to

Sort By:
Pageof 29
Clinical Genitourinary Cancer|February 27, 2018
Exposure to Multiple Lines of Treatment and Survival of Patients With Metastatic Renal Cell Carcinoma: A Real-world AnalysisRaffaele Ratta, Elena Verzoni, Massimo Di Maio, et al.
Tumori|January 31, 2007
Kit protein (CD117) and proliferation index (Ki-67) evaluation in well and poorly differentiated neuroendocrine tumorsLeonardo Ferrari, Silvia Della Torre, Paola Collini, et al.
Expert Review of Anticancer Therapy|June 10, 2026
Local treatment of the primary tumour in mHSPC in the ARPI era: incremental value or overtreatment?Simone Rota, Melanie Claps, Eleonora Gusmaroli, et al.
Tumori|July 5, 2003
Current treatments of neuroendocrine tumors role of biotherapy and chemotherapySilvia Della Torre, Giuseppe Procopio, Alberto Fusi, et al.
Tumori|February 12, 2004
Renal cancer treatment: a review of the literatureLuca Gattinoni, Massimiliano Alù, Leonardo Ferrari, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 29, 2014
Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinibRoberto Iacovelli, Giacomo Cartenì, Michele Milella, et al.
Pragmatic and Observational Research|November 17, 2025
Real-World Treatment Patterns and Overall Survival (OS) of Patients with Metastatic Castration-Resistant Prostate Cancer in ItalyMelania Dovizio, Daniela Castelletti, Paolo Luraghi, et al.
BJU International|November 17, 2010
Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castrationGiuseppe Procopio, Valentina Guadalupi, Maria Olga Giganti, et al.
Drugs in R&D|August 13, 2017
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?Paolo Grassi, Elena Verzoni, Raffaele Ratta, et al.
Oncology|November 8, 2014
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies: overall results from a large cohort of patientsGiuseppe Procopio, Isabella Testa, Elena Verzoni, et al.
Pageof 29